Oona Reardon provides expert advice and solutions in health economics, market access, biostatistics, and pricing for health technology companies. Oona's mission is to accelerate market access for health technology, so patients can achieve improved health outcomes or access alternative treatment options sooner. Oona has over 20 years of experience working across the healthcare sector in private, public, and academic positions.Oona leverages her unique combination of strategic and analytical skills to convey the value of healthcare interventions based on clinical trial evidence, economic modelling, and budget impact analyses. Oona has completed numerous health economic evaluations and has extensive expertise in various therapeutic areas, including oncology, rare diseases, immunology, nephrology, diabetes, cardiology, and neuroscience. Prior to Pulse Economics, Oona worked as a Senior Health Economics Manager at Labcorp, a PBAC submission evaluator at CHERE, a MSAC submission evaluator at HealthConsult and a market access and regulatory professional at several pharmaceutical companies. Oona holds a Master of Public Health with a major in Health Economics and a Bachelor of Science (Medical Physics) with Honours from the University of Technology Sydney.